Tommaso Viva

Dr. Tommaso Viva

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2023 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
MBMonica Barki
Monica Barki
MLMaurizio Losito
Maurizio Losito
MCMichela Maria Caracciolo
Michela Maria Caracciolo
TSTadafumi Sugimoto
Tadafumi Sugimoto
MRMarina Rovida
Marina Rovida
MGMarco Guazzi
Marco Guazzi
Aims: In acute heart failure (AHF), the consequences of impaired left atrial (LA) mechanics are not well understood. We aimed to define the clinical trajectory of LA mechanics by left atrial strain (LAS) analysis. Methods and results: Eighty-five consecutive AHF patients with reduced, mildly reduced, and preserved left ventricular ejection fraction (LVEF) were enrolled in the LAS-AHF trial and underwent LA mechanics analysis by speckle tracking echocardiography. Seventy-seven patients were followed-up (FU) at 6 and 12 months. At hospital admission, discharge, 6 and 12 months post-discharge, LA reservoir function (LAS), LA pump strain, LAVi, LA stiffness, indicators of right ventricular (RV) and left ventricular (LV) function, congestion indexes (B lines, inferior vena cava, X-ray congestion score index), and biomarkers (NT-pro-BNP) were measured. The primary outcome was time to first event of re-hospitalization, worsening HF, or cardiovascular death. From admission to discharge, RV function significantly improved after decongestion, whereas no significant differences were observed in LA dynamics and LV function. In sinus rhythm patients with mild or no mitral regurgitation, decongestion was associated with a significant improvement of LAS and LA pump strain rate during hospitalization. At 12 months, 24 CV events occurred and lack of LAS improvement at 12 months FU emerged as the most powerful predictor followed by NT-pro-BNP. Kaplan–Meier curves showed a better survival for LAS >16%, improvement of LAS > 5%, and an LAS/LAVi ratio >0.25%/mL/m2 compared with lower cut-off values [log-rank: heart rate (HR) 3.5, 95% confidence interval (CI) 1.8–7.3, P = 0.004; log-rank: HR 3.6, 95% CI 2–7.9, P < 0.01; log-rank: HR 3.27, 95% CI 1.4–7.7, P = 0.007]. Conclusion: In AHF of any LVEF, LA dynamics is highly predictive of re-hospitalization and cardiovascular outcome and allows to ease risk-stratification, potentially becoming an early reference target for improving long-term outcome.

26 June 2023 in Kidney360
Verified
Journal Article
Open access
GMGrégoire Masson
Grégoire Masson
TVTommaso Viva
Tommaso Viva
JHJustine Huart
Justine Huart
LWLaurent Weekers
Laurent Weekers
CBCatherine Bonvoisin
Catherine Bonvoisin
FJFrançois Jouret
François Jouret
Key Points: Surgical AVF ligation in KTRs is associated with a significant increase in diastolic BP while systolic BP remains stable. AVF closure in KTRs leads to an improvement of LV and LA morphology and a decrease in serum NT-proBNP levels. There is no significant effect of AVF ligation on kidney allograft function: The eGFR remains stable over time. Background: Kidney transplantation is considered as the best kidney replacement therapy, and arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis. The systematic ligation of a functioning AVF in stable kidney transplant recipients (KTRs) remains debatable. Methods: In this prospective study, we investigated the hemodynamic effect of the surgical closure of AVF in KTRs. Forty-three KTRs underwent an ambulatory BP monitoring before surgical closure of AVF (T0) and 12 months later (M12), as well as measurement of serum cardiac biomarkers (i.e., soluble suppression of tumorigenicity 2, N-terminal pro b-type natriuretic peptide [NT-proBNP], and galectin-3). Serum tests were also performed 6 months after AVF closure (M6). An echocardiographic examination was performed at each time point. All serum creatinine values were collected to compare the individual eGFR slopes before versus after AVF closure. The latest measure of the AVF flow before kidney transplantation was recorded. Results: Diastolic BP significantly rose from T0 to M12: +4.4±7.3 mm Hg (P = 0.0003) for 24h, +3.8±7.4 mm Hg (P = 0.0018) during the day, and +6.3±9.9 mm Hg (P = 0.0002) during the night, leading to an increased proportion of KTRs with European Society of Hypertension (ESH)-defined arterial hypertension after AVF ligation. No change was observed for systolic BP. NT-proBNP significantly dropped between T0 and M6 (345 [190; 553] to 230 [118; 458] pg/ml, P = 0.0001) and then remained stable from M6 to M12 while suppression of tumorigenicity 2 and galectin-3 levels did not change from T0 to M12. We observed a significant decrease in left ventricular (LV) end-diastolic volume, LV end-systolic volume, LV mass, interventricular septum diameter, left atrial volume, and tricuspid annular plane systolic excursion from T0 to M6 and then a stability from M6 to M12. LV ejection fraction and eGFR slope remained stable during the whole study. These observations remained unchanged after adjustment for AVF flow. Conclusion: The closure of a patent AVF in KTRs is associated with elevation of diastolic BP, drop in serum NT-proBNP levels, reduction of left ventricular and atrial dimensions, and stability of eGFR slope. Podcast: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/K360/2023_12_01_KID0000000000000198.mp3

6 October 2025 in European Heart Journal - Imaging Methods and Practice
Verified
Journal Article
Open access
TVTommaso Viva
Tommaso Viva
CFCorrado Fiore
Corrado Fiore
PLPatrizio Lancellotti
Patrizio Lancellotti
Three-dimensional echocardiography (3DE), via both transthoracic and transoesophageal approaches, has become an essential tool in the assessment of mitral valve (MV) disease, providing detailed anatomical and functional insights fundamental to both diagnosis and therapeutic planning. By offering a unique volumetric perspective, 3DE allows a comprehensive visualization of the entire MV apparatus, enhancing the capacity to appreciate anatomical and functional details. In mitral regurgitation (MR), 3DE adds pivotal information about leaflet morphology, annular geometry, and sub-valvular structures across all Carpentier subtypes, playing a central role in surgical and percutaneous procedural planning. 3D colour-mode imaging improves spatial localization of regurgitant jets and enables advanced MR quantification techniques. Specifically, 3D proximal isovelocity surface area and 3D vena contracta area offer improved accuracy over 2D methods, particularly in functional MR, and in multiple or complex jets. Additionally, the 3D indirect volumetric method and emerging semi-automated software are further tools for MR quantification. In mitral stenosis, 3D planimetry via transthoracic and transoesophageal echocardiography provides more accurate and reproducible measurements of the MV area compared with 2D, especially in challenging anatomies or suboptimal imaging planes. 3DE, especially using the transoesophageal approach, also improves commissural evaluation, which is essential for patient selection for percutaneous valvuloplasty. Overall, 3DE has redefined MV imaging by offering unparalleled anatomical and quantitative assessment. Its integration into routine clinical practice is critical for modern echocardiography and should be considered a core competency for cardiovascular imaging specialists.

25 January 2025 in Acta Cardiologica
Verified
Journal Article
Closed access
TVTommaso Viva
Tommaso Viva
SSSimona Sperlongano
Simona Sperlongano
MTMai-Linh Nguyen Trung
Mai-Linh Nguyen Trung
HPHélène Petitjean
Hélène Petitjean
PLPatrizio Lancellotti
Patrizio Lancellotti

18 September 2025 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
TVTommaso Viva
Tommaso Viva
AMAlessandro Masini
Alessandro Masini
MGMichele Gallazzi
Michele Gallazzi
VBVito Domenico Bruno
Vito Domenico Bruno
AMAntonio Miceli
Antonio Miceli
Edoardo ConteEdoardo Conte
Edoardo Conte
Background: Bicuspid aortic valve (BAV) is the most common congenital heart anomaly, often leading to significant aortic stenosis (AS) or aortic regurgitation (AR), which may require surgical intervention. Echocardiography is typically used for the diagnosis of BAV, and the integration of artificial intelligence (AI) can enhance diagnostic accuracy and guide surgical decisions. Case Summary: We present two patients with BAV: a 17-year-old male football player with isolated AR due to prolapse undergoing aortic valve repair, and a 68-year-old male with combined AS and AR, candidate for aortic valve replacement. AI-based tools assisted in characterizing the valvular disease and assessing its hemodynamic impact by estimating and averaging transvalvular gradients and velocity-time-integrals, reconstructing three-dimensional (3D) valve anatomy, and automatically calculating left ventricular volumes, ejection fraction (EF), and global longitudinal strain (GLS). This comprehensive assessment improved prognostic evaluation and helped tailor the treatment plan. Conclusion: AI in echocardiography holds great potential for diagnosis and planning the treatment of BAV disease. By enhancing image analysis and automating key diagnostic steps, AI can reduce diagnostic times and optimize patient outcomes. As AI-based tools continue to evolve and gain clinical validation, their integration into everyday practice will likely lead to a more efficient and accurate care for patients with valvular heart disease.

12 December 2025 in Acta Cardiologica
Verified
Journal Article
Closed access
TVTommaso Viva
Tommaso Viva
JZJessica Zannoni
Jessica Zannoni
ARAntonio Popolo Rubbio
Antonio Popolo Rubbio
LLLaura Lupi
Laura Lupi
EAEustachio Agricola
Eustachio Agricola
MTMaurizio Tusa
Maurizio Tusa
The predictive role of right ventricular dysfunction (RVD) in patients with functional mitral regurgitation (FMR) undergoing transcatheter edge-to-edge repair (TEER), as well as RV remodelling following the procedure, remains uncertain. We evaluated the prognostic impact of pre-procedural three-dimensional (3D) right ventricular ejection fraction (RVEF) in patients with FMR. Additionally, we assessed the RV reverse remodelling (RVRR) based on 3D volumes and ejection fraction six months after the procedure. Data from 74 patients treated with TEER for FMR were prospectively collected. Pre-procedural RVD, defined as 3D RVEF ≤45%, was observed in 47 patients (63.5%). Patients were divided into three groups according to pre-procedural 3D-RVEF: no RVD (No-RVD, RVEF >45%, n = 27), mild-to-moderate RVD (MRVD, RVEF 31-45%, n = 36), and severe RVD (SRVD, RVEF ≤30%, n = 11). Patients with SRVD demonstrated a significant higher rate of all-cause mortality compared with the other two groups (p = 0.04) and RVEF ≤ 30% was associated with all-cause death, independently of left ventricular ejection fraction (LVEF) and left atrial volume index (LAVi) (HR: 3.72, 95% CI 1.12-12.30, p = 0.03). At 6-month follow-up, only patients with pre-procedural MRVD showed a significant reduction in 3D RV volumes and an improvement in RVEF compared to baseline (p < 0.05). RVD was common among patients undergoing mitral TEER for FMR. Those with pre-procedural SRVD had worse mid-term survival compared to patients with MRVD and No-RVD. The group with MRVD was the only one to demonstrate an RVRR six months after the procedure.